Tumors of bone
- 26 June 2015
- book chapter
- other
- Published by Wiley
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling PathwayPLOS ONE, 2013
- Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosisNucleic Acids Research, 2013
- A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionNature Genetics, 2012
- High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomasGenes, Chromosomes and Cancer, 2011
- Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression dataGenes, Chromosomes and Cancer, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2010
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions: Identification of a Novel EWS-SP3 Fusion and of Additional Cases with the EWS-ETV1 and EWS-FEV FusionsThe Journal of Molecular Diagnostics, 2007
- Ewing Sarcoma with Novel Translocation t(2;16) Producing an In-Frame Fusion of FUS and FEVThe Journal of Molecular Diagnostics, 2007